Pages that link to "Q37048931"
Jump to navigation
Jump to search
The following pages link to Aldosterone and vascular inflammation (Q37048931):
Displaying 50 items.
- Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis (Q26781416) (← links)
- Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone (Q26785911) (← links)
- Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression (Q30317783) (← links)
- Attenuation of peripheral salt taste responses and local immune function contralateral to gustatory nerve injury: effects of aldosterone (Q30434591) (← links)
- Pathophysiology of sleep apnea (Q30440658) (← links)
- Rationale for Combining a Direct Renin Inhibitor with other Renin- Angiotensin System Blockers. Focus on Aliskiren and Combinations (Q30452640) (← links)
- Eplerenone attenuates pulse wave reflection in chronic kidney disease stage 3-4--a randomized controlled study (Q31118126) (← links)
- Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension (Q33667283) (← links)
- Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation (Q33725441) (← links)
- Aldosterone: role in the cardiometabolic syndrome and resistant hypertension (Q33736838) (← links)
- Mineralocorticoid receptor antagonists and the metabolic syndrome (Q34168923) (← links)
- Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia (Q34591546) (← links)
- Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension (Q34724494) (← links)
- Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis (Q34778607) (← links)
- Metabolic syndrome: definitions and controversies. (Q35047747) (← links)
- Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization (Q35087079) (← links)
- Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome (Q35113885) (← links)
- Role of Ca(2+)/calmodulin-dependent protein kinase kinase in adrenal aldosterone production (Q35436012) (← links)
- Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults. (Q35685538) (← links)
- Aldosterone-induced brain MAPK signaling and sympathetic excitation are angiotensin II type-1 receptor dependent (Q35965042) (← links)
- Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice (Q36000073) (← links)
- Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy (Q36068308) (← links)
- Electrical and Myocardial Remodeling in Primary Aldosteronism (Q36344672) (← links)
- Oxidative stress in the cardiorenal metabolic syndrome (Q36795759) (← links)
- Pathophysiology of vascular remodeling in hypertension (Q37077772) (← links)
- Angiotensin II regulation of adrenocortical gene transcription (Q37119192) (← links)
- Aldosterone activates endothelial exocytosis (Q37129370) (← links)
- Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study (Q37193640) (← links)
- Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study (Q37292583) (← links)
- Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children (Q37304780) (← links)
- The renin-angiotensin system as a primary cause of polyarteritis nodosa in rats (Q37310598) (← links)
- Resistant hypertension and hyperaldosteronism (Q37311440) (← links)
- Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism. (Q37541407) (← links)
- Type 2 diabetes mellitus and hypertension: an update (Q37617567) (← links)
- Hypoglycaemia increases aldosterone in a dose‐dependent fashion (Q37643031) (← links)
- Aldosterone and arterial hypertension (Q37660912) (← links)
- 11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice (Q37687153) (← links)
- Application of direct renin inhibition to chronic kidney disease (Q37758534) (← links)
- Aldosterone blockade in chronic kidney disease: can it improve outcome? (Q37772047) (← links)
- Salt, aldosterone, and insulin resistance: impact on the cardiovascular system (Q37778985) (← links)
- Superoxide anion and hydrogen peroxide-induced signaling and damage in angiotensin II and aldosterone action (Q37792074) (← links)
- Resistant hypertension in the high-risk metabolic patient (Q37799756) (← links)
- Hypertension treatment update: Focus on direct renin inhibition (Q37868721) (← links)
- Role of mineralocorticoid action in the brain in salt‐sensitive hypertension (Q37876462) (← links)
- Tissue-specific modulation of mineralocorticoid receptor function by 11β-hydroxysteroid dehydrogenases: An overview (Q37912407) (← links)
- Relations between large artery structure and function and aldosterone (Q37913954) (← links)
- Mineralocorticoid receptor antagonists for heart failure (Q37955919) (← links)
- The role of TWEAK/Fn14 in cardiac remodeling (Q38023271) (← links)
- Metabolic syndrome in patients with hematological diseases. (Q38044776) (← links)
- Mineralocorticoid receptor: a critical player in vascular remodeling (Q38238028) (← links)